The role of atrial dilatation in development of chronic atrial fibrillation

Project Information

NEUBERGER, HANS-RUPR

Grant agreement ID: QLG1-CT-2000-51236

Project closed

Start date 1 January 2001

End date 31 December 2002

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 140 600,00

EU contribution € 140 600,00

Coordinated by

UNIVERSITY OF MAASTRICHT
Netherlands

Objective

The project investigates whether chronic a trial dilatation plays a causal role in a trial fibrillation. It uses a new method in a well-established goat model and will help to develop effective therapeutic strategies against this important arrhythmia.

Fields of science

• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases › cardiac arrhythmia

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

UNIVERSITY OF MAASTRICHT

• EU contribution: No data
• Address: Universiteitssingel 50 ; 6200 MB MAASTRICHT ; Netherlands
• Total cost: No data